CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
 
	 | 
    3 | Alpha Beta | 
 
	 | 
    3.40 | 3-Layer(aba) Sandwich | 
 
	 | 
    3.40.640 | Aspartate Aminotransferase; domain 2 | 
 
	 | 
    3.40.640.10 | Type I PLP-dependent aspartate aminotransferase-like (Major domain) | 
Domain Context
CATH Clusters
| Superfamily | Type I PLP-dependent aspartate aminotransferase-like (Major domain) | 
| Functional Family | 
Enzyme Information
| 2.6.1.7 | 
							 Kynurenine--oxoglutarate transaminase. 
							based on mapping to UniProt Q8N5Z0 		
							L-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate. 
							-!- Also acts on 3-hydroxykynurenine. -!- The product 4-(2-aminophenyl)-2,4-dioxobutanoate is converted into kynurenate by a spontaneous reaction. 
						 | 
					
| 2.6.1.39 | 
							 2-aminoadipate transaminase. 
							based on mapping to UniProt Q8N5Z0 		
							L-2-aminoadipate + 2-oxoglutarate = 2-oxoadipate + L-glutamate. 
							
						 | 
					
UniProtKB Entries (1)
| Q8N5Z0 | 
						 AADAT_HUMAN 
						Homo sapiens 
						Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial 
					 | 
				
PDB Structure
| PDB | 4GE9 | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | 
					 Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions. 
					    
					    ACS Med Chem Lett 
					    
					 | 
			
